Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
34.96
-0.45 (-1.27%)
At close: Mar 24, 2026, 4:00 PM EDT
34.76
-0.20 (-0.57%)
After-hours: Mar 24, 2026, 5:50 PM EDT
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $5.67 billion as of March 24, 2026. Its market cap has increased by 632.28% in one year.
Market Cap
5.67B
Enterprise Value
5.01B
1-Year Change
632.28%
Ranking
Category
Stock Price
$34.96
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $5.67B, an increase of 4,466.08%. That is a compound annual growth rate of 95.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 5.70B | 5.54% |
| Dec 31, 2025 | 5.40B | 527.16% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protagonist Therapeutics | 6.29B |
| Kymera Therapeutics | 6.28B |
| Belite Bio | 5.95B |
| Rhythm Pharmaceuticals | 5.78B |
| Apogee Therapeutics | 5.51B |
| PTC Therapeutics | 5.50B |
| CG Oncology | 5.48B |
| Caris Life Sciences | 5.44B |